GE/G-Con aim for modular, mobile vax making

GE Healthcare and G-Con Manufacturing say they will collaborate on a portable bio-process manufacturing solution for vaccines. GE brings biopharma technology and a global presence; G-Con, its modular cleanroom technology.

GE says in a statement the deal moves it closer to its "vision of modular and possibly mobile flexible biopharmaceutical manufacturing facilities--the vaccine factory in a box."

Disposables-based vaccine manufacturing is a fast-moving technology space, and the GE/G-Con play faces worthy adversaries.

G-Con knows this, based on its participation in DARPA's Blue Angel initiative to demonstrate quickened vaccine production through a process involving tobacco plants. Fraunhofer USA and Medicago are also Blue Angel participants.

And Xcellerex will be another competitor. The disposable platform provider announced rapid swine flu production in a test last May with Pfenex and collaborators.

- see the G-Con release


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.